Governors Ask FDA to Remove IV Solution Import Barriers
Five Republican governors asked the Biden administration to collaborate with the FDA to identify foreign manufacturers that produce sterile IV solutions and the containers for those solutions.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
They asked the administration to "remove any barriers preventing the importation of sterile IV and peritoneal dialysis solutions from abroad, particularly those approved by the European Union."
The governors' Oct. 17 letter noted there is an emergency shortage of IV solution because a plant in Marion, North Carolina, which produced about 60% of domestic IV fluids, closed due to damage caused by Hurricane Helene.
"Hospital and health systems across our states are employing conservation strategies and exploring alternatives to protect sound clinical care in our states. But conservation strategies have limited effectiveness and are not sustainable strategies without increased production and reliable access," they wrote.
Kristi Noem of South Dakota, Jeff Landry of Louisiana, Jim Pillen of Nebraska, Henry McMaster of South Carolina and Mark Gordon of Wyoming signed the letter.